TC
KNSA icon

Tejara Capital’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Tejara Capital’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-42,649
Closed -$841K – 78
2024
Q1 		$841K Sell
42,649
-52,500
-55% -$1.03M 0.31% 55
2023
Q4 		$1.67M Buy
95,149
+60,149
+172% +$989K 0.7% 38
2023
Q3 		$608K Buy
35,000
+1,069
+3% +$18K 0.34% 49
2023
Q2 		$478K Sell
33,931
-14,569
-30% -$195K 0.24% 57
2023
Q1 		$522K Buy
+48,500
New +$639K 0.27% 60

Other funds holding KNSA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tejara Capital's KNSA Position: Q2 2024 in Review

Tejara Capital sold out of Kiniksa Pharmaceuticals (KNSA) in Q2 2024, closing a stake of 42,649 shares — an estimated $841K sold.

Tejara Capital first reported a position in KNSA in Q1 2023 and held it in 5 quarters. The position peaked at $1.67M in Q4 2023. 133 funds tracked by Wall St. Rank hold KNSA as of Q2 2024.

  • Tejara Capital reported no remaining Kiniksa Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Tejara Capital sold 42,649 Kiniksa Pharmaceuticals shares in Q2 2024, an estimated $841K.
  • Tejara Capital first reported a position in Kiniksa Pharmaceuticals in Q1 2023 and held it in 5 quarters.
  • Tejara Capital's Kiniksa Pharmaceuticals position peaked at $1.67M in Q4 2023.
  • 133 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2024.

Based on Tejara Capital's 13F filing for Q2 2024, filed 14 Aug 2024.